Cell Freezing Media Market To Reach $291.3 Million By 2030

Cell Freezing Media Market Growth & Trends

The global cell freezing media market size is expected to reach USD 291.3 million by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 9.62% from 2023 to 2030, driven by increasing adoption of ready to freezing media, coupled with growing pipeline of biopharmaceuticals leading to a higher demand for these products. In addition, increasing prevalence of chronic disorders, and risen significance of cells therapies in managing them have created traction for effective cell freezing medium.

The growing research and development activities to develop advanced therapies have resulted in increased demand for the cost-effective cryopreservation medium. The ability of ready to use media to reduce the ice crystals formation while cryopreserving viable cells eventually led to its increasing adoption among research community. Furthermore, the increased popularity of biopharmaceuticals due to improved safety and efficacy has cascaded huge investments from manufacturers to develop advanced biopharmaceuticals for life-threatening disorders.

The rapid research and development of COVID-19 vaccine and its continuous commercial production activities has also positively impacted as well as encouraged the biologics-based research activities and eventually boosted the market growth. The increasing market demand, growing competition among players and various application by end users has also attributed to advancements in formulations of cell freezing media and are now even available as per custom requirements. For instance, the Sigma Aldrich brand of Merck KGaA offers freezing media solutions for stem cells application while providing optimal recovery and cells survival.

Rapid advancements in cellular therapy research and growing adoption of cell therapies in various disorders have created a robust demand in the global market. Cell freezing media has a very important role in maintaining functionality of cells during the thawing and freezing process, which is vital for cell therapies applications. In addition, various strategies undertaken by market participants to bolster applications of cellular therapies in managing chronic disorders are projected to accelerate market expansion. For instance, in September 2022, Scribe Therapeutics and Sanofi announced partnership to commercialize CRISPR based therapies for cancer.

 Request a free sample copy or view report summary: Cell Freezing Media Market Report

Cell Freezing Media Market Report Highlights

• The DMSO (dimethyl sulfoxide) segment dominated the market in 2022 with a revenue share of 51.46% and is attributed to the established gold standard from years of using DMSO in traditional cryopreservation for suspending the metabolic activities of cells

• The stem cells lines segment has the largest application of cell freezing media, whereas cancer cell lines expected to witness fastest growth owing to the increasing clinical success rate of cell and gene therapy products

• Across end use segment, the pharmaceutical and biotechnology companies segment dominated the market with the revenue share of 42.42% in 2022. The higher revenue growth is attributed to the continuous growth and commercial success of biopharmaceuticals coupled with the expanding portfolio of the major pharmaceutical companies

• North America region dominated the global market in 2022, owing to expanding pipeline for biopharmaceuticals, a large pool of key players, rising demand for cell freezing media, and advanced healthcare infrastructure along with developed economy

Cell Freezing Media Market Segmentation

Grand View Research has segmented the global cell freezing media market based on product, application, end-use, and region:

Cell Freezing Media Product Outlook (Revenue, USD Million, 2018 - 2030)

• DMSO

• With Serum

• Without Serum

• Glycerol

• With Serum

• Without Serum

• Others

Cell Freezing Media Application Outlook (Revenue, USD Million, 2018 - 2030)

• Stem Cell lines

• Cancer Cell Lines

• Others

Cell Freezing Media End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical and Biotechnological Companies

• Research and Academic Institutes

• Others

Cell Freezing Media RegionalOutlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Cell Freezing Media Market

• Thermo Fisher Scientific, Inc.

• Merck KGaA

• Sartorius AG

• BioLife Solutions, Inc.

• Bio-Techne

• HiMedia Laboratories

• PromoCell GmbH,

• Capricorn Scientific

• Cell Applications, Inc.

• STEMCELL Technologies.

• AMSBIO

• Cell Systems

• BPS Bioscience, Inc.